Skip to main content
. 2021 Sep 22;37:169–184. doi: 10.1016/j.jare.2021.09.009

Fig. 1.

Fig. 1

Identification of a prognostic miRNA signature in CC. (A) KM analyses of OS and DFS for 5 candidate prognostic miRNAs in CC patients (stage I–IIA). (B-C) KM analyses in CC patients based on the risk score of 5 candidate prognostic miRNAs. (D-E) Kaplan-Meier analyses in CC patients (stage I–IIA) based on the risk score of 5 candidate prognostic miRNAs. (F-G) ROC curve for 1, 3, and 5 year survival prediction by the prognostic miRNA score model (H) Relative mRNA expression of 5 candidate prognostic miRNAs. (I) miR-532-5p expression was significantly downregulated in the primary site of CC with LNM compared with that without LNM. (J) miR-532-5p expression in three CC cell lines with different metastatic potentials.